Filing Flows › Zymeworks (ZYME) › Q2 2026 › vs Q1 2026
Zymeworks (ZYME) Q2 2026 vs Q1 2026 (quarter over quarter)
Zymeworks's revenue rose $2.2M (+91%) from $2.4M in Q1 2026 to $4.6M in Q2 2026.
Zymeworks, Q2 2026: revenue $4.6M (-91% year over year), operating margin -919.0%, net loss $45.0M, operating cash flow −$31.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $4.6M | $2.4M | $2.2M | +91% |
| Income tax benefit | $273K | $2.2M | −$1.9M | -88% |
| Net loss | $45.0M | $44.2M | $857K | +2% |
| Costs & expenses | $49.9M | $49.5M | $356K | +0.7% |
| Operating costs | $46.8M | $49.5M | −$2.8M | -6% |
| Interest & other, net | $3.1M | −$765K | $3.9M | — |
| Research & development | $27.4M | $34.5M | −$7.0M | -20% |
| General & admin | $19.3M | $15.1M | $4.3M | +28% |
| Operating cash sources | $45.0M | $44.2M | $857K | +2% |
| Depreciation & amortization | $1.1M | $1.1M | −$6K | -0.5% |
| Share-based compensation | $11.3M | $6.9M | $4.4M | +63% |
| Working capital & other | $604K | −$9.6M | $10.2M | — |
| Cash used in operations | $31.9M | $45.7M | −$13.8M | -30% |
| Net loss absorbed | $45.0M | $44.2M | $857K | +2% |
Questions
How much did Zymeworks's revenue grow quarter over quarter in Q2 2026?
Zymeworks's revenue rose $2.2M (+91%) from $2.4M in Q1 2026 to $4.6M in Q2 2026.